These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35534674)

  • 81. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
    Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
    CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage.
    Chan R; Wei CY; Chen YT; Benet LZ
    AAPS J; 2016 May; 18(3):757-66. PubMed ID: 26951484
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults.
    Shirzadi M; Saunes M; Reimers A; Brodtkorb E
    Seizure; 2021 Jul; 89():12-18. PubMed ID: 33951602
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine.
    Anjum N; Polak ME; Ardern-Jones M; Cooper HL
    Clin Exp Dermatol; 2014 Apr; 39(3):307-9. PubMed ID: 24635066
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical application of pharmacogenomics.
    Ma JD; Lee KC; Kuo GM
    J Pharm Pract; 2012 Aug; 25(4):417-27. PubMed ID: 22689709
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
    Moon J; Park HK; Chu K; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin JW; Lee ST; Jung KH; Jung KY; Jeon D; Kim DW; Yu KS; Jang IJ; Kang HR; Park HW; Lee SK
    Epilepsia; 2015 Oct; 56(10):e161-7. PubMed ID: 26282450
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
    Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
    Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
    [No Abstract]   [Full Text] [Related]  

  • 89. Incidence of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions in Malaysia.
    Fong SL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Ho JH; Lai PSM; Ng WL
    J Clin Pharmacol; 2022 Aug; 62(8):983-991. PubMed ID: 35230712
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients.
    Ramanujam B; Ihtisham K; Kaur G; Srivastava S; Mehra NK; Khanna N; Singh M; Tripathi M
    J Epilepsy Res; 2016 Dec; 6(2):87-92. PubMed ID: 28101480
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation.
    Baftiu A; Lima MH; Svendsen K; Larsson PG; Johannessen SI; Landmark CJ
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1153-1160. PubMed ID: 31001654
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.
    Yip VL; Marson AG; Jorgensen AL; Pirmohamed M; Alfirevic A
    Clin Pharmacol Ther; 2012 Dec; 92(6):757-65. PubMed ID: 23132554
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China.
    Sun D; Yu CH; Liu ZS; He XL; Hu JS; Wu GF; Mao B; Wu SH; Xiang HH
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):146-150. PubMed ID: 24496695
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.
    Yan S; Xiong H; Shao F; Zhang W; Yang F; Qi Z; Chen S; He L; Jiang M; Su Y; Zhu H; Qin S; Zhu Q; Luo X; Xing Q
    Pharmacogenomics J; 2019 Jun; 19(3):277-285. PubMed ID: 30237582
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
    Mushiroda T
    Rinsho Byori; 2014 Jan; 62(1):83-8. PubMed ID: 24724431
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
    Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
    J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hypersensitivity reactions to antiepileptic drugs in children.
    Atanasković-Marković M; Janković J; Tmušić V; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Škorić D
    Pediatr Allergy Immunol; 2019 Aug; 30(5):547-552. PubMed ID: 30951222
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population.
    Sukasem C; Sririttha S; Tempark T; Klaewsongkram J; Rerkpattanapipat T; Puangpetch A; Boongird A; Chulavatnatol S
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):565-574. PubMed ID: 32134161
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
    Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.